Related Experiment Videos
Lack of pharmacokinetic interaction between cimetidine and tirilazad mesylate
J C Fleishaker1, L K Hulst, G R Peters
1Clinical Phamacokinetics Unit, Upjohn Company, Kalamazoo, Michigan 49007.
Pharmaceutical Research
|February 1, 1994
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Population pharmacokinetics and pharmacodynamics of rivaroxaban in patients with non-valvular atrial fibrillation: results from ROCKET AF.
Journal of clinical pharmacology·2014
Proof of concept: a PhRMA position paper with recommendations for best practice.
Clinical pharmacology and therapeutics·2010
A comparison of the pharmacokinetics and tolerability of the anti-migraine compound almotriptan in healthy adolescents and adults.
Cephalalgia : an international journal of headache·2004
Comparison of ximelagatran, an oral direct thrombin inhibitor, with enoxaparin for the prevention of venous thromboembolism following total hip replacement. A randomized, double-blind study.
Journal of thrombosis and haemostasis : JTH·2003
Lack of effect of reboxetine on cardiac repolarization.
Clinical pharmacology and therapeutics·2001
Pharmacokinetics of reboxetine in healthy, elderly volunteers.
European journal of drug metabolism and pharmacokinetics·2001
Biosurfactant-Based Interventions for Improving Lung Function and Controlling Inflammation.
Pharmaceutical research·2026
Federated Estimation of Population Pharmacokinetic Models with Exact Equivalence to Pooled-Data Analysis.
Pharmaceutical research·2026
Drug Repurposing for Metabolic-Associated Fatty Liver Disease: Current Evidence, Challenges, and Future Perspectives.
Drug design, development and therapy·2026
Using Biomod2 and spatial quality modeling for comprehensive production zoning of Bupleurum chinense DC.
Frontiers in plant science·2026